EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 120 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,464,000 | +80.5% | 35,200 | 0.0% | 0.84% | +53.8% |
| Q2 2016 | $1,365,000 | -4.3% | 35,200 | 0.0% | 0.55% | -7.8% |
| Q1 2016 | $1,426,000 | -54.3% | 35,200 | 0.0% | 0.59% | -32.6% |
| Q4 2015 | $3,121,000 | -64.8% | 35,200 | -70.6% | 0.88% | -48.3% |
| Q3 2015 | $8,876,000 | -22.3% | 119,900 | -15.1% | 1.70% | +57.7% |
| Q2 2015 | $11,426,000 | +68.3% | 141,300 | -12.8% | 1.08% | +68.0% |
| Q1 2015 | $6,790,000 | +119.0% | 162,100 | -19.0% | 0.64% | +115.8% |
| Q4 2014 | $3,100,000 | +22.5% | 200,000 | 0.0% | 0.30% | +13.8% |
| Q3 2014 | $2,530,000 | -11.7% | 200,000 | 0.0% | 0.26% | +6.1% |
| Q2 2014 | $2,866,000 | +12.4% | 200,000 | 0.0% | 0.25% | +18.3% |
| Q1 2014 | $2,550,000 | – | 200,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 112,666 | $1,777 | 0.65% |
| Smith, Graham & Co., Investment Advisors, LP | 273,099 | $4,306,771 | 0.54% |
| BRANDES INVESTMENT PARTNERS, LP | 1,134,363 | $17,888,904 | 0.35% |
| TANG CAPITAL MANAGEMENT LLC | 118,857 | $1,874,375 | 0.26% |
| Virtus Investment Advisers, Inc. | 20,867 | $329,073 | 0.22% |
| DENALI ADVISORS LLC | 32,300 | $509,371 | 0.18% |
| Nebula Research & Development LLC | 11,473 | $180,929 | 0.10% |
| SCOUT INVESTMENTS, INC. | 131,192 | $1,995,430 | 0.05% |
| XTX Topco Ltd | 15,050 | $237,339 | 0.04% |
| PDT Partners, LLC | 19,745 | $311,379 | 0.04% |